Background: Health care practitioners, regulators, payers and other customers are demanding sophisticated clinical and health-outcomes data and analyses to support the approval, reimbursement and prescription of new medicines. We must reorient our thinking along the lines of value delivered, articulating value propositions that are appropriate and relevant to right customers, and proactively impact the environment from early stage gates and throughout the product’s lifecycle.
Program Overview: The primary responsibility of the Global Medical Affairs team is to develop the Global Medical Affairs strategic plan, namely evidence generation (phase IIIB/IV studies), scientific communications, and scientific engagement.
The Alexion Global Medical Affairs Fellowship will give the fellow the opportunity to:
Learn how to develop a Global Medical Affairs Plan (MAP) and an integrated evidence/scientific communication plan under the direction of the Global Medical Affairs Leader (GMAL).
Develop capabilities on how to implement designated elements of the MAP, such as preparation for advisory boards and symposia in full compliance with scientific engagement standards and regulations.
Provide insightful medical/scientific input to brand campaigns and launches.
Support the development of promotional, non-promotional, and training materials in accordance with codes/regulations.
Support excellence in external engagement with key stakeholders (HCPs, patients, payers, and regulators) to gain a deep understanding of customer needs.
Learn how to identify data gaps and design appropriate studies to support those data gaps in partnership with commercial and development colleagues, including:
Supporting the Integrated Global Medical Affairs team
Reviewing Investigator Sponsored Research (ISR) proposals to assess their strategic value based on scientific merit and strategic need
Developing Alexion-sponsored research
The Alexion Global Medical Affairs Fellowship will provide the fellow the opportunity to further develop core medical competencies, namely:
Scientific and technical expertise;
Medical and value access;
Executional and operational excellence; and
Engagement skills (both verbal and written).
Fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an Accreditation Council for Pharmacy Education (ACPE) accredited college of pharmacy.
Candidates must have strong written and verbal communication skills and an interest in pursuing a career in the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the two-year fellowship. No visa sponsorship will be provided.
Participation in the American Society of Health-Systems Pharmacist (ASHP) Midyear Clinical Meeting Personnel Placement Service (PPS) is strongly encouraged, but not required. Candidates are encouraged to request a preliminary interview at the ASHP midyear meeting through the PPS website.
In addition to your application in PPS, please visit the MCPHS application portal to initiate your formal application http://www.mcphs.edu/pharmdfellow. For each position you request an interview for at PPS, please select it on the portal. Application materials must be received by December 20th.
The formal application materials below must be received by December 20th. Submit via the online portal (https://www.mcphs.edu/academics/postgraduate-opportunities/biopharmaceutical-fellowships).
Letter of intent
3 Letters of recommendation
Contact information only for three references for letters of recommendation
Please note: Final letters of recommendations must be received by December 20th.
Alexion is a global biopharmaceutical company focused on developing and delivering life-changing therapies for patients with devastating and rare diseases. Patients with these life-threatening diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know... people's lives depend on our work.
Alexion was established in the U.S. in 1992 and became a public company in 1996 (NASDAQ: ALXN). Alexion's employees around the world serve patients in approximately 50 countries. Our ambition is to be the global leader in rare diseases by leveraging our 20+ years of expertise in complement biology and our capabilities in hematology, nephrology, neurology and metabolic disorders to bring additional life-changing therapies to patients.
MCPHS University provides an academic environment to guide and support fellows toward a successful career in the biopharmaceutical industry. As a private institution with a history of specializing in health sciences, MCPHS University offers programs that embody scholarship, professional service, and community outreach.
Through MCPHS University, the fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS University faculty and company program leaders mentor fellows according to their scholarly and professional interests throughout the two-year program.
As an adjunct instructor at MCPHS, the fellow may have the opportunity to:
• Develop, coordinate, and teach courses
• Co-precept pharmacy students on advanced experiential rotations
• Create and publish scholarly research and/or review articles
• Present research at scientific and clinical meetings
• Participate in professional development seminars with other fellows and residents from MCPHS-affiliated programs